A Phase 2 Study of Axulin in Patients with Type 2 Diabetes

Recruiting Phase 2 TS000011

Study Description

Testing the safety and dosage range of a natural health product called HP-211 (Axulin) to see if it helps control blood sugar levels in people with Type 2 Diabetes.

Study Details

Registry ID:: TS000011
Conditions:: Not specified
Phase:: Phase 2
Target Enrollment:: 300 participants
Start Date:: April 13, 2026
Healthy Volunteers:: No

Study Locations (4 sites)

Tekton Research – Midlothian
Midlothian, VirginiaUnited States, United States
Tekton Research – McKinney
McKinney, TexasUnited States, United States
Tekton Research – Irving
Irving, TexasUnited States, United States
Tekton Research – San Antonio
San Antonio, TexasUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.org.

View full study details and check eligibility →